BTK inhibitors in multiple sclerosis
Bruton's tyrosine kinase inhibitors studied in multiple sclerosis.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 1, 1, 2, 2, 2.
All papers from the last 12 months
52 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Multiple sclerosis: Advances in diagnosis, biomarkers, and disease managementJ Neuroimmunol2026 Oct 7PMID 42868862
- Utilization of Brain Physiologically Based Pharmacokinetic Modeling in Support of CNS Drug Development: Case Example of FenebrutinibAAPS J2026 Oct 5PMID 42834264
- Horizon Scanning of Multiple Sclerosis Expenditure in Italy (2025-2029): Updated Insights from the Oracle ModelNeurol Ther2026 Oct 3PMID 42828703
- Exploring Progressive Multiple Sclerosis and the Therapeutic Potential of BTK Inhibitors Based on EBV-driven B Cell-microglia InteractionsCNS Neurol Disord Drug Targets2026 Oct 1PMID 42861741
- Comparator Event Rates, Baseline Activity, and Operational Selection Pressure in Relapsing Multiple Sclerosis Trials: A Meta-Epidemiological AnalysisEur J Neurol2026 OctPMID 42858119Meta-analysis
- High-throughput primary B cell cytokines assay for drug screening in multiple sclerosisBiomed Pharmacother2026 OctPMID 42697043
- Tolebrutinib in nonrelapsing SPMS: regulatory divergence and the limits of relapse based labelsMult Scler Relat Disord2026 OctPMID 42567027
- B-cell targeting strategies for the treatment of multiple sclerosis: from non-cellular therapies to CAR-engineered cell therapiesNeurol Sci2026 Sep 24PMID 42782403Review
- Tolebrutinib liver safety: A detailed overviewMult Scler Relat Disord2026 SepPMID 42546561Review
- Targeting progressive multiple sclerosis: Toward mechanism-informed precision medicineJ Intern Med2026 SepPMID 42482223Review
More neurology trends
All specialties →New myasthenia gravis therapies
FcRn blockers and complement inhibitors in myasthenia gravis.
Key point: Terminal complement pathway inhibitors and neonatal Fc receptor antagonists are reshaping myasthenia gravis treatment, with robust evidence of efficacy and safety.
Wearable seizure detection
Wearable devices and algorithms to detect or forecast seizures.
Autoimmune encephalitis
Antibody-mediated encephalitis, its diagnosis and treatment.
Brain-computer interfaces
Devices that translate brain signals into control of computers or limbs.
Alpha-synuclein seed amplification
Seed amplification assays that detect misfolded alpha-synuclein.
Thrombectomy for large-core stroke
Endovascular thrombectomy in stroke with a large ischaemic core.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"multiple sclerosis"[tiab] AND ("BTK inhibitor*"[tiab] OR Bruton[tiab] OR tolebrutinib[tiab] OR evobrutinib[tiab] OR fenebrutinib[tiab])Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.